X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - ARABNEWSNETWORK.PS - Ala Une - 02/Sep 06:49

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”). A class action lawsuit […]

Articles similaires

Sorry! Image not available at this time

Aviat Networks, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

mangaloremirror.com - 12/Sep 16:53

BOSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) — Block & Leviton is investigating Aviat Networks, Inc. (Nasdaq: AVNW) for potential securities law...

Sorry! Image not available at this time

Aviat Networks, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

mangaloremirror.com - 12/Sep 16:53

BOSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) — Block & Leviton is investigating Aviat Networks, Inc. (Nasdaq: AVNW) for potential securities law...

Sorry! Image not available at this time

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Sage Therapeutics, Inc. (SAGE) on Behalf of Investors

healthtechzone.com - 12/Sep 13:11

Sorry! Image not available at this time

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Sage Therapeutics, Inc. (SAGE) on Behalf of Investors

healthtechzone.com - 12/Sep 13:11

Sorry! Image not available at this time

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Aviat Networks, Inc. (AVNW) on Behalf of Investors

healthtechzone.com - 12/Sep 22:17

Sorry! Image not available at this time

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Elastic N.V. (ESTC) on Behalf of Investors

healthtechzone.com - 11/Sep 16:50

Sorry! Image not available at this time

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Elastic N.V. (ESTC) on Behalf of Investors

healthtechzone.com - 11/Sep 16:50

Sorry! Image not available at this time

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

drugs.com - 03/Sep 01:09

LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

drugs.com - 05/Sep 05:09

SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

drugs.com - 05/Sep 05:09

SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...

Les derniers communiqués

  • Aucun élément